| ADR Ontology |
| ADR Term |
Pachymeningitis |
| ADR ID |
BADD_A08164 |
| ADR Hierarchy |
|
| Description |
Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) [MeSH] |
| MedDRA Code |
10053658 |
| MeSH ID |
D008581
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Hypertrophic pachymeningitis | Cerebral pachymeninx hypertrophy | Pachymeningitis | Meningitis | Meningitides | Pachymeningitides |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01110 | Hydroxyurea | 0.000112% | | | BADD_D02392 | Zoledronic acid | 0.010020% | | | BADD_D02464 | Fingolimod | 0.000241% | |
| The 1th Page 1
Total 1 Pages
|
|
